KD Logo

Goldman initates Krystal Biotech Inc (KRYS) stock to a Buy

Krystal Biotech Inc’s recent filing unveils that its Director Gangolli Julian S unloaded Company’s shares for reported $3.28 million on May 20 ’24. In the deal valued at $164.13 per share,20,000 shares were sold. As a result of this transaction, Gangolli Julian S now holds 0 shares worth roughly $0.0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, Krishnan Suma sold 25,000 shares, generating $4,274,040 in total proceeds. Upon selling the shares at $170.96, the President, R&D now owns 1,550,882 shares.

Before that, Krishnan Krish S sold 25,000 shares. Krystal Biotech Inc shares valued at $4,274,040 were divested by the President and CEO at a price of $170.96 per share. As a result of the transaction, Krishnan Krish S now holds 1,550,882 shares, worth roughly $274.24 million.

Goldman initiated its Krystal Biotech Inc [KRYS] rating to a Buy in a research note published on November 20, 2023; the price target was $160. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late October with a ‘”an Overweight”‘ rating. Citigroup began covering KRYS with “Buy” recommendation on October 12, 2023. Berenberg started covering the stock on September 07, 2023. It rated KRYS as “a Buy”.

Price Performance Review of KRYS

On Monday, Krystal Biotech Inc [NASDAQ:KRYS] saw its stock jump 7.55% to $176.83. Over the last five days, the stock has gained 7.65%. Krystal Biotech Inc shares have risen nearly 42.54% since the year began. Nevertheless, the stocks have risen 38.15% over the past one year. While a 52-week high of $189.97 was reached on 03/05/24, a 52-week low of $93.95 was recorded on 02/22/24. SMA at 50 days reached $165.06, while 200 days put it at $134.36. A total of 1.55 million shares were traded, compared to the trading of 0.21 million shares in the previous session.

Levels Of Support And Resistance For KRYS Stock

The 24-hour chart illustrates a support level at 172.53, which if violated will result in even more drops to 168.24. On the upside, there is a resistance level at 182.05. A further resistance level may holdings at 187.28. The Relative Strength Index (RSI) on the 14-day chart is 63.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.73, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 21.59%. Stochastics %K at 61.31% indicates the stock is a holding.

The most recent change occurred on April 18, 2023 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $102 price target.

Most Popular